Catalyst President Nancy Bradish Myers will moderate two panel discussions during DIA’s 50th Annual Meeting, to be held June 15-19, 2014 in San Diego. Her sessions, both scheduled for June 17, will explore:

  • 3D printing, or bioprinting: Potential impact of this type of disruptive technology on drug discovery and health care delivery, and potential challenges for regulators; DIA recently previewed the panel in a press release
  • Digital Health: Opportunities created by this rapidly evolving field, the potential impact on the health care system, and implications for regulators

Both panels will feature a range of stakeholders, including FDA, industry and advocacy groups.